JPMorgan Chase & Co. Increases SpringWorks Therapeutics (NASDAQ:SWTX) Price Target to $74.00
SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report) had its price target hoisted by investment analysts at JPMorgan Chase & Co. from $73.00 to $74.00 in a note issued to investors on Wednesday, Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside […]
More Stories
Procyon Advisors LLC Sells 3,673 Shares of Intel Co. (NASDAQ:INTC)
Procyon Advisors LLC reduced its holdings in Intel Co. (NASDAQ:INTC – Free Report) by 15.8% in the 1st quarter, Holdings...
Procyon Advisors LLC Has $490,000 Stake in Wells Fargo & Company (NYSE:WFC)
Procyon Advisors LLC grew its stake in shares of Wells Fargo & Company (NYSE:WFC) by 2.8% in the first quarter,...
Imagine Lithium (CVE:ILI) Stock Price Up 33.3% – What’s Next?
Shares of Imagine Lithium Inc. (CVE:ILI – Get Free Report) rose 33.3% during mid-day trading on Saturday . The company...
Transition Metals (CVE:XTM) Trading 62.5% Higher – Should You Buy?
Transition Metals Corp. (CVE:XTM – Get Free Report) shares were up 62.5% during mid-day trading on Saturday . The stock...
Alba Mineral Resources (LON:ALBA) Trading Down 11.1% – Here’s Why
Shares of Alba Mineral Resources plc (LON:ALBA – Get Free Report) traded down 11.1% during trading on Saturday . The...
Centurion Minerals (CVE:CTN) Shares Up 33.3% – Here’s What Happened
Centurion Minerals Ltd. (CVE:CTN – Get Free Report)’s stock price traded up 33.3% during trading on Saturday . The stock...